Published in Innovations (Phila) on March 30, 2015
Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med (2013) 6.33
POINT: Prosthesis-patient mismatch does not affect survival for patients greater than 70 years of age undergoing bioprosthetic aortic valve replacement. J Thorac Cardiovasc Surg (2008) 3.10
A prospective, single-center clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation. J Thorac Cardiovasc Surg (2004) 2.95
The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures. J Thorac Cardiovasc Surg (2003) 2.82
Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns. Circulation (2010) 2.57
Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support. Ann Thorac Surg (2007) 2.22
Isolating the entire posterior left atrium improves surgical outcomes after the Cox maze procedure. J Thorac Cardiovasc Surg (2008) 2.22
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08
Early stenosis of Medtronic Mosaic porcine valves in the aortic position. J Thorac Cardiovasc Surg (2008) 2.05
The influence of mechanical properties on wall stress and distensibility of the dilated ascending aorta. J Thorac Cardiovasc Surg (2003) 2.05
The bicuspid aortic valve. Curr Probl Cardiol (2005) 1.93
Atrial fibrillation propagates through gaps in ablation lines: implications for ablative treatment of atrial fibrillation. Heart Rhythm (2008) 1.87
Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg (2002) 1.86
Microwave ablation for atrial fibrillation: dose-response curves in the cardioplegia-arrested and beating heart. Ann Thorac Surg (2006) 1.83
Long-term outcome of bilateral lung volume reduction in 250 consecutive patients with emphysema. J Thorac Cardiovasc Surg (2003) 1.80
The cox-maze procedure for lone atrial fibrillation: a single-center experience over 2 decades. Circ Arrhythm Electrophysiol (2011) 1.79
Epicardial microwave ablation on the beating heart for atrial fibrillation: the dependency of lesion depth on cardiac output. J Thorac Cardiovasc Surg (2006) 1.73
The Cox maze IV procedure: predictors of late recurrence. J Thorac Cardiovasc Surg (2011) 1.73
The impact of the lung allocation score on short-term transplantation outcomes: a multicenter study. J Thorac Cardiovasc Surg (2007) 1.65
Chronic transmural atrial ablation by using bipolar radiofrequency energy on the beating heart. J Thorac Cardiovasc Surg (2002) 1.63
Maintenance of myocyte volume homeostasis during stress by diazoxide is cardioprotective. Ann Thorac Surg (2007) 1.63
Surgical treatment of atrial fibrillation: predictors of late recurrence. J Thorac Cardiovasc Surg (2005) 1.61
Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation (2005) 1.59
Potential for detrimental hyperinflation after lung transplantation with application of negative pleural pressure to undersized lung grafts. J Thorac Cardiovasc Surg (2003) 1.54
Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg (2009) 1.53
Risk factors for leg harvest surgical site infections after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg (2003) 1.51
Delayed paraplegia after thoracic and thoracoabdominal aneurysm repair: a continuing risk. Ann Thorac Surg (2003) 1.51
Successful management of unremitting spasm of the nongrafted right coronary artery after off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg (2007) 1.51
Benefits of resection for metachronous lung cancer. J Thorac Cardiovasc Surg (2004) 1.50
Radial artery grafts in women: utilization and results. Ann Thorac Surg (2005) 1.48
Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A). Circ Cardiovasc Interv (2013) 1.48
Deterioration and mortality among patients with United Network for Organ Sharing status 2 heart disease: caution must be exercised in diverting organs. J Thorac Cardiovasc Surg (2006) 1.45
Long-term outcomes in valve replacement surgery for infective endocarditis. Ann Thorac Surg (2007) 1.43
The effect of ablation technology on surgical outcomes after the Cox-maze procedure: a propensity analysis. J Thorac Cardiovasc Surg (2007) 1.43
Significance of neurologic complications in the modern era of cardiac transplantation. Ann Thorac Surg (2007) 1.42
Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis. J Thorac Cardiovasc Surg (2011) 1.41
Spontaneous atrioventricular groove disruption during off-pump coronary artery bypass grafting. Ann Thorac Surg (2005) 1.39
Results of lung volume reduction surgery in patients meeting a national emphysema treatment trial high-risk criterion. J Thorac Cardiovasc Surg (2004) 1.39
Outcomes after resection of giant emphysematous bullae. Ann Thorac Surg (2004) 1.33
Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial. J Thorac Cardiovasc Surg (2011) 1.30
The Cox-maze IV procedure for lone atrial fibrillation: a single center experience in 100 consecutive patients. J Interv Card Electrophysiol (2011) 1.30
Aortic enlargement and late reoperation after repair of acute type A aortic dissection. Ann Thorac Surg (2007) 1.29
Atrial tachyarrhythmias after the maze procedure: incidence and prognosis. Circulation (2004) 1.29
A new era in the surgical treatment of atrial fibrillation: the impact of ablation technology and lesion set on procedural efficacy. Ann Surg (2006) 1.26
Physiological consequences of bipolar radiofrequency energy on the atria and pulmonary veins: a chronic animal study. Ann Thorac Surg (2003) 1.26
Efficacy and safety of right and left atrial ablations on the beating heart with irrigated bipolar radiofrequency energy: a long-term animal study. J Thorac Cardiovasc Surg (2006) 1.25
Noninvasive, quantitative assessment of left ventricular function in ischemic cardiomyopathy. J Surg Res (2004) 1.24
Repair of ischemic mitral regurgitation does not increase mortality or improve long-term survival in patients undergoing coronary artery revascularization: a propensity analysis. Ann Thorac Surg (2004) 1.23
Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg (2002) 1.21
The effect of robotic assistance on learning curves for basic laparoscopic skills. Am J Surg (2002) 1.21
Importance of geometry and refractory period in sustaining atrial fibrillation: testing the critical mass hypothesis. Circulation (2005) 1.19
Right atrial and ventricular adaptation to chronic right ventricular pressure overload. Circulation (2005) 1.19
Recurrent mitral regurgitation and risk factors for early and late mortality after mitral valve repair for functional ischemic mitral regurgitation. Ann Thorac Surg (2008) 1.19
Altered left ventricular geometry changes the border zone temporal distribution of stress in an experimental model of left ventricular aneurysm: a finite element model study. Circulation (2002) 1.18
Evaluation of a novel cryoablation system: in vivo testing in a chronic porcine model. Innovations (Phila) (2013) 1.17
Animal studies of epicardial atrial ablation. Heart Rhythm (2009) 1.17
The impact of CHADS2 score on late stroke after the Cox maze procedure. J Thorac Cardiovasc Surg (2012) 1.16